Prof. Christophe Massard is a medical oncologist and a professor of cancerology at the University of Paris-Saclay. He began his career at the Gustave Roussy Institute. Over the past 15 years, Prof. Massard has been the principal investigator in over 100 Phase I/II trials and has developed world-renowned expertise in the clinical development of new innovative drugs for cancer treatment. In 2013, he participated in the creation then was appointed Head of the Department of Therapeutic Innovation and Early Trials (DITEP) to strengthen these core aspects of clinical development at Gustave Roussy. He has contributed to more than 100 scientific publications published in leading peer-reviewed journals, including the Lancet Oncology. For 2 years, he has been involved in the optimization of clinical strategy with Biomunex.